Based on the latest report data from Future Market Insights, the global medical device market is projected to grow from USD 719.63 billion in 2026 to USD 1,288.75 billion in 2036. Behind the 6% compound annual growth rate is a synchronized restructuring of procurement logic, regional momentum, and regulatory pathways.
According to a Future Market Insights report, the global medical IoT market is expected to reach US$280.5 billion by 2026, increasing to US$1,164.8 billion by 2036, with a compound annual growth rate of 15.3%. Hardware accounts for 46%, telemedicine for 32%, and India is the fastest-growing market.
The global medical device market was valued at $537.38 billion in 2025 and is expected to reach $826.53 billion by 2034. The integration of population aging and AI technology is reshaping the industry landscape, with minimally invasive surgery and remote monitoring becoming growth highlights.
The Business Research Company's latest report shows that the global medical device market is expected to achieve a CAGR of 9.2% from 2026 to 2030, with AI, digital health, and smart hospitals becoming the core growth drivers.
The global wearable medical device market is expected to reach $167.8 billion by 2035, with a compound annual growth rate of 14.2%. Driven by policy, technology, and capital, the healthcare industry is undergoing a transition from periodic checkups to continuous monitoring.
According to the report, the global wearable medical device market reached $44.5 billion in 2025, and is expected to grow to $167.8 billion by 2035, at a compound annual growth rate of 14.2%. CMS expanding reimbursement for remote monitoring, the EU's digital health strategy, and the miniaturization of biosensors are the main drivers.
The self-disinfecting medical device market is rapidly expanding at a compound annual growth rate of 14%, driven by rising hospital infection rates, a surge in surgical volumes, and increasing healthcare expenditure. This article analyzes market dynamics, key technology trends, and regional competitive landscape.
A study by the American Medical Association shows that most doctors believe data from consumer wearable devices (such as smartwatches) have clinical value, but issues such as accuracy, liability, and data integration still hinder their widespread adoption.
Driven by personalized medicine, regulatory maturity, and declining costs of multi-laser systems, the global additive manufacturing market for medical devices is expected to grow at a compound annual growth rate of 15–20% from 2026 to 2035. Orthopedic implants and surgical guides account for 55–70% of revenue, and in-house 3D printing laboratories in hospitals are accelerating in adoption.
ZS Impact Institute report shows 90% of consumers trust AI health advice as much as that of doctors, early diagnosis could save $500 billion, promoting a zero-distance care model.
MiniMed launches the Abbott-manufactured Instinct continuous glucose monitor in Europe, targeting over 4.5 million Abbott CGM users, aiming to drive insulin pump sales growth through sensor selection.
According to the latest PwC report, the total value of medical technology M&A transactions in the first half of 2026 reached $36.5 billion, led by Boston Scientific's acquisition of Penumbra and Danaher's acquisition of Masimo, indicating that the industry's M&A momentum remains strong.
According to a report by Growth Market Reports, the global capsule endoscopy system market is expected to grow from $1.09 billion in 2024 to $2.15 billion by 2033, at a compound annual growth rate of 8.2%. The rising incidence of gastrointestinal diseases, AI-assisted image analysis, and the demand for non-invasive diagnostics are the key driving factors.
Deloitte's latest research shows that diagnostic manufacturers are shifting from traditional product suppliers to a B2B2C model, with AI, EHR workflow integration, and interoperability becoming key to the next stage of growth.